Literature DB >> 28108320

Modulation on brain gray matter activity and white matter integrity by APOE ε4 risk gene in cognitively intact elderly: A multimodal neuroimaging study.

Suping Cai1, Yuanyuan Jiang2, Yubo Wang1, Xiaoming Wu3, Junchan Ren1, Min Seob Lee4, Sunghoon Lee5, Liyu Huang6.   

Abstract

Apolipoprotein E (APOE) ε4 allele is the genetic risk factor with the most established evidence for sporadic Alzheimer's disease. Previous neuroimaging studies have demonstrated insufficiently consistent functional and structural changes among healthy APOE ε4 carriers when compared to non-carriers. Here, in a cognitively intact elderly group (a total of 110: 45 APOE ε4 carriers, 65 non-carriers), we aimed to investigate the potential role of APOE ε4 in the modulation of grey matter activity, white matter integrity, and brain morphology before the development of clinically significant symptoms and signs, by methods of: amplitude of low frequency fluctuations and regional homogeneity analysis based on resting state fMRI, and fiber tractography approach based on diffusion tensor imaging. Our results revealed that compared to non-carriers, APOE ε4 carriers showed: (1) an inconsistent pattern of activity change in the default mode network, including increased gray matter activity in anterior cingulate cortex and medial prefrontal cortex and decreased activity in precuneus; (2) lower mean diffusivity (MD) in fibers of corona radiata and corpus callosum, and lower axial diffusivity in genu of corpus callosum; and (3) significant positive correlation between the MD value of the right superior corona radiate and gross white matter volume; significant negative correlation between the MD value of the right superior corona radiate and Mini-Mental State Examination (MMSE) score. Our results suggested that APOE ε4 gene can modulate gray matter activity and white matter integrity in cognitive and memory related regions, even before any clinical or neuropsychic symtoms or signs of imminent disease.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  APOE ε4; Alzheimer’s disease; Cognitively intact elderly; DTI; Gray matter activity; MRI; White matter integrity; fMRI

Mesh:

Substances:

Year:  2017        PMID: 28108320     DOI: 10.1016/j.bbr.2017.01.027

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  5 in total

1.  Effects of apolipoprotein E gene polymorphism on the intracellular Ca2+ concentration of astrocytes in the early stages post injury.

Authors:  Haitao Wu; Shuai Zhou; Hongxin Zhao; Yuyu Wang; Xiaozhong Chen; Xiaochuan Sun
Journal:  Exp Ther Med       Date:  2017-11-23       Impact factor: 2.447

2.  Subjective cognitive and non-cognitive complaints and brain MRI biomarkers in the MEMENTO cohort.

Authors:  Virginie Dauphinot; Vincent Bouteloup; Jean-François Mangin; Bruno Vellas; Florence Pasquier; Frédéric Blanc; Olivier Hanon; Audrey Gabelle; Cédric Annweiler; Renaud David; Vincent Planche; Olivier Godefroy; Thérèse Rivasseau-Jonveaux; Marie Chupin; Clara Fischer; Geneviève Chêne; Carole Dufouil; Pierre Krolak-Salmon
Journal:  Alzheimers Dement (Amst)       Date:  2020-07-05

Review 3.  Imaging Alzheimer's genetic risk using diffusion MRI: A systematic review.

Authors:  Judith R Harrison; Sanchita Bhatia; Zhao Xuan Tan; Anastasia Mirza-Davies; Hannah Benkert; Chantal M W Tax; Derek K Jones
Journal:  Neuroimage Clin       Date:  2020-07-22       Impact factor: 4.881

4.  Default Mode Network Analysis of APOE Genotype in Cognitively Unimpaired Subjects Based on Persistent Homology.

Authors:  Liqun Kuang; Jiaying Jia; Deyu Zhao; Fengguang Xiong; Xie Han; Yalin Wang
Journal:  Front Aging Neurosci       Date:  2020-06-30       Impact factor: 5.750

5.  Modulation on Glutamic Pathway of Frontal-Striatum-Thalamus by rs11146020 and rs3813296 Gene Polymorphism in First-Episode Negative Schizophrenia.

Authors:  Suping Cai; Yahui Lv; Kexin Huang; Wei Zhang; Qiang Wang; Liyu Huang; Jijun Wang
Journal:  Front Neurosci       Date:  2020-04-21       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.